Encompass Health (EHC) vs Fresenius Medical Care (FMS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Encompass Health (EHC) has outperformed Fresenius Medical Care (FMS) over the past year, losing 1.5% versus a loss of 22.9%. Over five years, EHC leads with a +127.8% price change compared with -41.1% for FMS. Encompass Health is the larger company by market cap ($12.24 billion vs $11.21 billion), about 1.1 times the size.
On valuation, Fresenius Medical Care trades at a lower forward P/E (7.1x vs 18.6x for Encompass Health). Fresenius Medical Care offers the higher dividend yield (7.07% vs 0.61%). Fresenius Medical Care converts more of its revenue into profit, with a net margin of 22.3% versus 9.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EHC | FMS |
|---|---|---|
| Share price | $124.07 | $21.07 |
| Market cap | $12.24B | $11.21B |
| 1-day change | +1.25% | +0.91% |
| YTD return | +15.45% | -12.34% |
| 1-year return | -1.50% | -22.87% |
| 5-year return | +127.79% | -41.12% |
| P/E ratio (TTM) | 20.75 | 10.86 |
| Forward P/E | 18.58 | 7.05 |
| EPS (TTM) | $5.98 | $1.94 |
| Dividend yield | 0.61% | 7.07% |
| Annual dividend | $0.76 | $1.49 |
| Revenue (latest FY) | $5.94B | $4.97B |
| Revenue growth (YoY) | +10.46% | -63.98% |
| Net income (latest FY) | $566.20M | $1.11B |
| Gross margin | — | 95.33% |
| Operating margin | — | 45.39% |
| Net margin | 9.54% | 22.33% |
| 52-week high | $127.99 | $27.54 |
| 52-week low | $92.77 | $20.02 |
| Distance from 52-week high | -3.06% | -23.49% |
| Analyst consensus | strong_buy | hold |
| Avg. price target upside | +19.42% | +11.20% |
| Average volume | 915.90K | 756.94K |
| Shares outstanding | 98.65M | 532.22M |
| Employees | 29,699 | 107,226 |
| Sector | Health Care | Health Care |
| Industry | Hospital/Nursing Management | Misc Health and Biotechnology Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EHC has outperformed FMS by 21.4 percentage points over the past year.
- Encompass Health trades at a higher earnings multiple (20.7x vs 10.9x trailing P/E).
- Fresenius Medical Care offers a meaningfully higher dividend yield (7.07% vs 0.61%).
- Fresenius Medical Care is more profitable, keeping 22.3 cents of every revenue dollar as net income versus 9.5 cents for Encompass Health.
- Encompass Health grew revenue faster in its latest fiscal year (+10.46% vs -63.98%).
About Encompass Health
EHC stock →Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Health Care · Hospital/Nursing Management · 29,699 employees
About Fresenius Medical Care
FMS stock →Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Health Care · Misc Health and Biotechnology Services · 107,226 employees
EHC vs FMS FAQ
Which is bigger, Encompass Health or Fresenius Medical Care?
Encompass Health (EHC) is larger, with a market capitalization of $12.24B compared with $11.21B for Fresenius Medical Care (FMS).
Which stock has performed better over the past year, EHC or FMS?
EHC returned -1.50% over the past 12 months, compared with -22.87% for FMS (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, EHC or FMS?
FMS has the lower trailing P/E at 10.9, versus 20.7 for EHC. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Encompass Health or Fresenius Medical Care?
Fresenius Medical Care has the higher yield at 7.07%, compared with 0.61% for Encompass Health.
Are Encompass Health and Fresenius Medical Care in the same industry?
Both are in the Health Care sector, but in different industries: Hospital/Nursing Management for Encompass Health and Misc Health and Biotechnology Services for Fresenius Medical Care.